Tradestie Institutional Equity Comparison Engine
SLN vs CAMP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SLN Overall Edge
SLN Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Silence Therapeutics Plc American Depository Share (SLN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SLN trades at N/M Forward P/E with -10475.6% operating margin (+197.2% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, SLN sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SLN N/M vs CAMP N/M Fwd P/E
Growth & Margin Winner
SLN
Op Margin -10475.6% vs -991.8% ยท YoY +197.2% vs +138.9%
Momentum & Technical Winner
SLN
1Y +190.0% vs -2.4% ยท 52W Pos 100% vs 23%
Options & Structure Winner
SLN
UNCLASSIFIED (50th %ile IV) vs UNCLASSIFIED (N/A IV)
SLN
NASDAQ
Silence Therapeutics Plc American Depository Share
Pharmaceutical Preparations
$19.80
+0.03% 1D
Market Cap
$1.2B
1M Return
+1.15%
1Y Return
+189.97%
Forward P/E
N/M
Unified AI Score
45.2 / 100
HOLD
Tech 25.0
Fund 34.0
Flow 50.0
Mom 30.0
CAMP
NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap
$238.5M
1M Return
+27.39%
1Y Return
-2.44%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 34.0
Fund 40.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SLN +189.97%
CAMP -2.44%
Spread: +192.41 pp (SLN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SLN TTM Op. Margin: -10475.6%
CAMP TTM Op. Margin: -991.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SLN vs CAMP. Trailing 12-month operating profitability (SLN -10475.6% vs CAMP -991.8%) and valuation multiples (SLN N/M vs CAMP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SLN | CAMP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $238.5M | Larger Scale | SLN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +197.2% | +138.9% | Higher Growth | SLN |
| Operating Margin (TTM) Profitability | -10475.6% | -991.8% | Higher Margin | CAMP |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -90.4% | -146.1% | Higher ROE | SLN |
| 52-Week Range Position Momentum | 100% ($4โ$20) | 23% ($3โ$8) | Stronger Trend | SLN |
| Beta / 30D Volatility Risk Regime | 1.92ฮฒ ยท 4% Vol | 1.35ฮฒ ยท 94% Vol | Lower Realized Risk | SLN |
| Unified Institutional Score Composite Signal | 45.2 / 100 (HOLD) | 43.9 / 100 (HOLD) | Higher Composite | SLN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SLN vs CAMP Buy Guide
SLN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
CAMP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SLN nor CAMP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.